Jones Financial Companies
LYRA

Jones Financial Companies’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Jones Financial Companies’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-210
Closed -$647 – 4851
2025
Q4 		$647 Hold
210
– – ﹤0.01% 4114
2025
Q3 		$1.36K Buy
210
+200
+2,000% +$1.47K ﹤0.01% 3815
2025
Q2 		$91 Hold
10
– – ﹤0.01% 3952
2025
Q1 		$69 Hold
10
– – ﹤0.01% 3645
2024
Q4 		$103 Hold
10
– – ﹤0.01% 3350
2024
Q3 		$133 Buy
+10
New +$147 ﹤0.01% 2962

Other funds holding LYRA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Jones Financial Companies's LYRA Position: Q1 2026 in Review

Jones Financial Companies sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 210 shares — an estimated $647 sold.

Jones Financial Companies first reported a position in LYRA in Q3 2024 and held it in 6 quarters. The position peaked at $1.36K in Q3 2025. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.

  • Jones Financial Companies reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
  • Jones Financial Companies sold 210 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $647.
  • Jones Financial Companies first reported a position in LYRA THERAPEUTICS INC in Q3 2024 and held it in 6 quarters.
  • Jones Financial Companies's LYRA THERAPEUTICS INC position peaked at $1.36K in Q3 2025.
  • 1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.